Clinical Trial Update: Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing postprandial blood glucose control using BioChaperone Combo with insulin lispro (Humalog Mix 25) in people with Type 1 Diabetes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BioChaperone Combo
• Humalog (insulin lispro)

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED